Er-Reboa Plus
Payments companies reported to CMS as associated with Er-Reboa Plus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Er-Reboa Plus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Er-Reboa Plus
These are the largest totals companies reported as associated with Er-Reboa Plus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Rasmussen | Rochester, MN | Vascular Surgery | $225,702.29 |
| Marshall Spalding | Columbus, OH | Surgery | $28,933.48 |
| Jonathan Nguyen | Atlanta, GA | Plastic Surgery | $18,932.02 |
| Jonathan Morrison | Rochester, MN | Vascular Surgery | $7,353.07 |
| Jacob Glaser | Temple, TX | Surgical Critical Care | $4,967.84 |
| Bellal Joseph | Detroit, MI | Surgery | $1,996.99 |
| James Betz | Columbus, OH | Adult Health (Nurse Practitioner) | $1,786.10 |
| Kelsey Cage | Altanta, GA | Surgery | $1,648.30 |
| William Vassy | Gainesville, GA | Trauma Surgery | $1,584.26 |
| Robert Cohen | Dallas, TX | Obstetrics & Gynecology | $1,151.77 |
Prescribed Er-Reboa Plus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.